SV2A (Synaptic vesicle glycoprotein 2A) variants and mutations

SV2A (also known as Synaptic vesicle glycoprotein 2A) is a human protein-coding gene encoding a synaptic vesicle glycoprotein 2A protein. A glycoprotein in synaptic-vesicle membranes that helps regulate controlled secretion in neurons and endocrine cells. It supports the readily releasable vesicle pool and efficient neurotransmitter release, and SV2A is strongly relevant to epilepsy research. This analysis covers 1,001 SV2A variants and mutations. Of these, 98% have computational variant effect predictions. Disease context includes epilepsy, Seizure, and Bilateral tonic-clonic seizure. Example SV2A variants include M1?, E2Q, and E3*.

Variant analysis overview

Variant and mutation evidence

Clinical, disease, and population context

Protein structure and variant hotspots

Data sources

Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, PharmGKB, MaveDB, LitVar.

Notable SV2A variants

Examples include M1?, E2Q, E3*, E3D, E3G, E3K, G4D, G4S. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.